#PreventativeMedicine

A groundbreaking study recently published in the Mayo Clinic Proceedings has unveiled a potential new “gold standard” in cholesterol treatment, which could prevent over 330,000 deaths annually caused by cardiovascular diseases. Spearheaded by an international team led by Professor Maciej Banach from the John Paul II Catholic University in Lublin, this research represents the largest meta-analysis to date examining the efficacy of cholesterol-lowering treatments for those at high risk of heart attacks and strokes. The study found that combining statins with ezetimibe, instead of using statins alone, significantly lowers “bad” LDL cholesterol and reduces mortality from cardiovascular diseases.